Lucid Group Inc
F:CH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lucid Group Inc
F:CH2
|
US |
|
U
|
Uniqa Insurance Group AG
VSE:UQA
|
AT |
|
Telefonica SA
MAD:TEF
|
ES |
|
C
|
Commercial Metals Co
SWB:CMS
|
US |
|
N
|
Nokia Oyj
BMV:NOKN
|
FI |
|
X
|
Xylem Inc
LSE:0M29
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
SWB:CPM
|
HK |
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
B
|
Bank Central Asia Tbk PT
F:BZG2
|
ID |
|
S
|
Singapore Telecommunications Ltd
XBER:SIT4
|
SG |
|
M
|
Mettler-Toledo International Inc
F:MTO
|
US |
|
CorVel Corp
NASDAQ:CRVL
|
US |
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
N
|
Netflix Inc
SWB:NFC
|
US |
|
C
|
Cardinal Health Inc
XBER:CLH
|
US |
|
E
|
Emira Property Fund
JSE:EMI
|
ZA |
|
F
|
Fanuc Corp
SWB:FUC
|
JP |
|
N
|
New Oriental Education & Technology Group Inc
HKEX:9901
|
CN |
Balance Sheet
Balance Sheet Decomposition
Lucid Group Inc
Lucid Group Inc
Balance Sheet
Lucid Group Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
352
|
614
|
6 263
|
1 736
|
1 370
|
1 607
|
998
|
|
| Cash Equivalents |
352
|
614
|
6 263
|
1 736
|
1 370
|
1 607
|
998
|
|
| Short-Term Investments |
1
|
1
|
0
|
2 177
|
2 490
|
2 424
|
631
|
|
| Total Receivables |
0
|
0
|
3
|
20
|
52
|
112
|
190
|
|
| Accounts Receivables |
0
|
0
|
3
|
20
|
52
|
112
|
177
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
13
|
|
| Inventory |
1
|
1
|
127
|
834
|
696
|
408
|
1 110
|
|
| Other Current Assets |
70
|
46
|
114
|
145
|
149
|
323
|
371
|
|
| Total Current Assets |
423
|
663
|
6 507
|
4 912
|
4 757
|
4 874
|
3 300
|
|
| PP&E Net |
143
|
713
|
1 344
|
2 382
|
3 032
|
3 474
|
4 220
|
|
| PP&E Gross |
143
|
713
|
1 344
|
2 382
|
3 032
|
3 474
|
4 220
|
|
| Accumulated Depreciation |
15
|
25
|
86
|
273
|
501
|
788
|
1 222
|
|
| Long-Term Investments |
0
|
0
|
0
|
530
|
543
|
1 050
|
512
|
|
| Other Long-Term Assets |
14
|
27
|
31
|
55
|
181
|
249
|
355
|
|
| Total Assets |
580
N/A
|
1 403
+142%
|
7 882
+462%
|
7 879
0%
|
8 513
+8%
|
9 648
+13%
|
8 387
-13%
|
|
| Liabilities | ||||||||
| Accounts Payable |
13
|
17
|
41
|
229
|
109
|
134
|
488
|
|
| Accrued Liabilities |
49
|
162
|
43
|
75
|
230
|
372
|
629
|
|
| Short-Term Debt |
0
|
1
|
15
|
10
|
73
|
126
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
4
|
11
|
8
|
7
|
756
|
|
| Other Current Liabilities |
35
|
5
|
292
|
614
|
589
|
526
|
764
|
|
| Total Current Liabilities |
97
|
185
|
396
|
938
|
1 008
|
1 165
|
2 636
|
|
| Long-Term Debt |
0
|
2
|
1 993
|
2 073
|
2 075
|
2 078
|
2 151
|
|
| Other Liabilities |
30
|
40
|
1 583
|
519
|
578
|
1 232
|
599
|
|
| Total Liabilities |
127
N/A
|
227
+80%
|
3 972
+1 647%
|
3 530
-11%
|
3 661
+4%
|
4 475
+22%
|
5 386
+20%
|
|
| Equity | ||||||||
| Common Stock |
1 074
|
2 494
|
0
|
0
|
0
|
1 300
|
2 284
|
|
| Retained Earnings |
638
|
1 357
|
6 066
|
7 370
|
10 199
|
12 913
|
15 611
|
|
| Additional Paid In Capital |
16
|
38
|
9 996
|
11 752
|
15 066
|
16 808
|
16 337
|
|
| Treasury Stock |
0
|
0
|
21
|
21
|
21
|
21
|
21
|
|
| Other Equity |
0
|
0
|
0
|
12
|
5
|
2
|
12
|
|
| Total Equity |
453
N/A
|
1 175
+159%
|
3 909
+233%
|
4 350
+11%
|
4 852
+12%
|
5 173
+7%
|
3 001
-42%
|
|
| Total Liabilities & Equity |
580
N/A
|
1 403
+142%
|
7 882
+462%
|
7 879
0%
|
8 513
+8%
|
9 648
+13%
|
8 387
-13%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
162
|
162
|
165
|
183
|
230
|
303
|
327
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|